Press Release

Category Added in a WPeMatico Campaign

Cision PR Newswire3 weeks ago
0

SDR Ventures Advises JK Concepts, Inc. on Acquisition by JEB Capital Partners

DENVER, Oct. 7, 2025 /PRNewswire/ — SDR Ventures is pleased to announce that JK Concepts, Inc. (“JK Concepts” or “the…
Read More »
Cision PR Newswire3 weeks ago
0

UNITS® Moves Up the Franchise Times Top 400 List

Leading Moving and Portable Storage Franchise Climbs to No. 383 in 2025 Ranking CHARLESTON, S.C., Oct. 7, 2025 /PRNewswire/ — UNITS®…
Read More »
Cision PR Newswire3 weeks ago
0

Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

FLASH 2 Study Interim Efficacy Analysis Targeted for 1H2026 Enrollment Update Remains on Track for 4Q2025 PRINCETON, N.J., Oct. 7,…
Read More »
Cision PR Newswire3 weeks ago
0

AllocateRite Introduces Audit-Ready AI Marketing Compliance Platform

NEW YORK, Oct. 7, 2025 /PRNewswire/ — AllocateRite, the world’s first deterministic AI-powered wealth management platform, today announced the launch…
Read More »
Cision PR Newswire3 weeks ago
0

Yann Goarin Joins AAXIS to Accelerate AI-Native Venture Development

LOS ANGELES, Oct. 7, 2025 /PRNewswire/ — AAXIS, a premier digital commerce and transformation consultancy, is thrilled to announce the…
Read More »
Business Wire3 weeks ago

Redwire Announces Planned Board Refreshment

General (RET) James McConville and Dorothy D. Hayes to Join as Independent Directors; Jonathan Baliff and John S. Bolton to…
Read More »
Business Wire3 weeks ago

Arrowhead Pharmaceuticals Files CTA for Investigational ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia

– ARO-DIMER-PA is designed to selectively silence the expression of two genes with a single RNAi molecule using Arrowhead’s proprietary…
Read More »
Business Wire3 weeks ago

Progentos Therapeutics Names Paul Frohna Chief Medical Officer

Veteran Translational Medicine and Clinical Development Leader Joins as Company Prepares to Advance its Lead Program for Remyelination in Multiple…
Read More »
Business Wire3 weeks ago

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today…
Read More »
Business Wire3 weeks ago

SonoThera™ Presents New Data at ESGCT 2025 Demonstrating Expression of Full-Length Human Dystrophin Using Targeted, Ultrasound-Mediated Delivery to Treat Duchenne Muscular Dystrophy

New data demonstrates the ability of UMD technology to deliver genetic medicines, allowing for full-length human dystrophin protein expression in…
Read More »

Previous page Next page